China Resources Medical Holdings Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Hai Yu

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	1.8yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	1.8yrs
Gemiddelde ambtstermijn bestuur	2.5yrs

Recente managementupdates

Recent updates

CEO

Hai Yu (56 yo)

1.8yrs

Tenure

Mr. Hai Yu is Chief Executive Officer & Executive Director of China Resources Medical Holdings Company Limited from February 27, 2023. He is the general manager of China Resources Health Group Limited, and...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Baojie Shan	VP & Executive Director	2.9yrs	CN¥3.24m	geen gegevens
Qing Song	Executive Chairman of the Board	6.3yrs	CN¥71.00k	0.031% HK$ 1.5m
Hai Yu	CEO & Executive Director	1.8yrs	geen gegevens	geen gegevens
Min Yang	CFO & Executive Director	1.4yrs	geen gegevens	geen gegevens
Ming Fai Chung	Company Secretary	less than a year	geen gegevens	geen gegevens

1.8yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 1515 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Baojie Shan	VP & Executive Director	3.3yrs	CN¥3.24m	geen gegevens
Qing Song	Executive Chairman of the Board	6.3yrs	CN¥71.00k	0.031% HK$ 1.5m
Hai Yu	CEO & Executive Director	1.8yrs	geen gegevens	geen gegevens
Min Yang	CFO & Executive Director	1.4yrs	geen gegevens	geen gegevens
Yuning Fu	Honorary Chairman	8yrs	geen gegevens	geen gegevens
Tingmei Fu	Independent Non-Executive Director	1.8yrs	geen gegevens	geen gegevens
Ting Yuk Wu	Independent Non-Executive Director	6.3yrs	CN¥257.00k	geen gegevens
Kwok Kong Kwong	Independent Non-Executive Director	11.2yrs	CN¥257.00k	geen gegevens
Lu Ge	Non-Executive Director	1.2yrs	geen gegevens	0.0051% HK$ 245.5k
Peng Zhou	Independent Non-Executive Director	1.2yrs	CN¥81.00k	geen gegevens

2.5yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 1515 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.5 jaar), wat duidt op een nieuw bestuur.

China Resources Medical Holdings Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Independent Non-Executive Director recently sold HK$2.6m worth of stock

China Resources Medical Holdings Company Limited, Annual General Meeting, Jun 05, 2024

China Resources Medical Holdings Company Limited Announces Board and Committee Changes

China Resources Medical Holdings Company Limited Announces Board Changes

China Resources Medical Holdings Company Limited Announces Board Changes

Less than half of directors are independent

Recent updates

Investor sentiment deteriorates as stock falls 18%

Investor sentiment improves as stock rises 19%

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

New minor risk - Profit margin trend

Upcoming dividend of HK$0.055 per share

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

China Resources Medical Holdings Company Limited Announces Interim (Semi-Annual) for the Interim Dividend for the Six Months Ended 30 June 2024, Payable on October 25, 2024

China Resources Medical Holdings Company Limited Announces Interim (Semi-Annual) for the Interim Dividend for the Six Months Ended 30 June 2024, Payable on October 25, 2024

China Resources Medical Holdings Company Limited to Report First Half, 2024 Results on Aug 26, 2024

Now 21% undervalued after recent price drop

China Resources Medical Holdings Company Limited Approves the Final Dividend for the Year Ended December 31, 2023, Payable on July 19, 2024

Upcoming dividend of CN¥0.06 per share

Independent Non-Executive Director recently sold HK$2.6m worth of stock

Dividend of CN¥0.06 announced

China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024

China Resources Medical Holdings Company Limited, Annual General Meeting, Jun 05, 2024

Full year 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.11 in FY 2022)

Now 24% undervalued after recent price drop

China Resources Medical Holdings Company Limited to Report Fiscal Year 2023 Results on Mar 19, 2024

Now 20% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

China Resources Medical Holdings Company Limited Announces Board and Committee Changes

First half 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.16 in 1H 2022)

China Resources Medical Holdings Company Limited to Report First Half, 2023 Results on Aug 22, 2023

Investor sentiment deteriorates as stock falls 15%

China Resources Medical Holdings Company Limited Announces Board Changes

China Resources Medical Holdings Company Limited Approves Final Dividend for the Year Ended December 31, 2022, Payable on July 19, 2023

Upcoming dividend of HK$0.037 per share at 0.6% yield

Full year 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.33 in FY 2021)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

China Resources Medical Holdings Company Limited Announces Board Changes

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.16 in 1H 2021)

China Resources Medical Holdings Company Limited to Report First Half, 2022 Results on Aug 23, 2022

Investor sentiment improved over the past week

China Resources Medical Holdings Company Limited Declares A Final Dividend for the Year Ended December 31, 2021

China Resources Medical Holdings Company Limited Declares A Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.12 per share

Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.25 in FY 2020)

Less than half of directors are independent

China Resources Medical Holdings Company Limited Proposes Final Dividend for Fiscal Year 2021, Payable on or Before July 19, 2022

Investor sentiment improved over the past week

China Resources Medical Holdings Company Limited to Report Fiscal Year 2021 Results on Mar 25, 2022

China Resources Medical Holdings Company Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2021

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.086 in 1H 2020)

Non-Executive Director Yan Wang has left the company

Independent Non-Executive Director recently sold HK$4.7m worth of stock

Investor sentiment improved over the past week

Upcoming dividend of HK$0.088 per share

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.31 in FY 2019)

China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended December 31, 2020

Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.31 in FY 2019)

China Resources Medical Holdings Company Limited to Report Fiscal Year 2020 Results on Mar 26, 2021

New 90-day high: HK$7.35

New 90-day high: HK$6.83

New 90-day high: HK$6.00

New 90-day high: HK$5.69

New 90-day low: HK$4.63

First half earnings released

First half earnings released

New 90-day high - HK$5.81

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd